•
Dec 31, 2020

Omega Healthcare Q4 2020 Earnings Report

Announced fourth quarter 2020 results, highlighting strong AFFO and FAD along with strategic investments and capital market activities.

Key Takeaways

Omega Healthcare Investors reported a net income of $63.1 million, or $0.27 per common share, for the quarter ended December 31, 2020. The company completed $98 million in new investments and issued $153 million of equity during the quarter. They also issued $700 million in 3.375% notes due in 2031.

Net income for the quarter was $63.1 million, or $0.27 per common share.

NAREIT Funds From Operations (FFO) was $173.3 million, or $0.73 per common share.

Adjusted Funds From Operations (AFFO) was $192.5 million, or $0.81 per common share.

Funds Available for Distribution (FAD) was $182.9 million.

Total Revenue
$264M
Previous year: $247M
+6.9%
EPS
$0.81
Previous year: $0.78
+3.8%
Gross Profit
$261M
Previous year: $243M
+7.1%
Cash and Equivalents
$164M
Previous year: $24.1M
+578.1%
Total Assets
$9.5B
Previous year: $9.8B
-3.0%

Omega Healthcare

Omega Healthcare

Omega Healthcare Revenue by Segment

Omega Healthcare Revenue by Geographic Location

Forward Guidance

Given the continued uncertainty related to the COVID-19 pandemic, its impact on the financial performance of the Company’s operators and the extent of future necessary government support to the operators, the Company will not be providing 2021 earnings guidance.

Revenue & Expenses

Visualization of income flow from segment revenue to net income